Neuropsychiatric Symptoms in HIV Patients after Switching from Nevirapine to Dolutegravir in Cipto Mangunkusumo Hospital, Jakarta

Introduction. Dolutegravir (DTG) is one of the effective antiretroviral therapies (ART) for suppressing HIV replication and has a favorable safety profile. However, reports regarding neuropsychiatric side effects, especially in patients transitioning from a nevirapine (NVP) regimen to dolutegravir,...

Description complète

Détails bibliographiques

Auteurs principaux:	Metra Adi Pratama, Rudi Putranto, Herqutanto Herqutanto, Aisyah Syahrani, Veritea Natali, Aljira Fitya Hapsari, Meivina Ramadhani Pane, Evy Yunihastuti
Format:	Artigo
Langue:	Indonésio
Publié:	Department of Internal Medicine, Faculty of Medicine Universitas Indonesia 2025-06-01
Collection:	Jurnal Penyakit Dalam Indonesia
Sujets:	arv art dolutegravir hiv neuropsychiatric nevirapine
Accès en ligne:	https://scholarhub.ui.ac.id/jpdi/vol12/iss2/4/
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!